Maintenance Use of Antidepressants in Dutch General Practice: Non-Guideline Concordant
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is hardly evidence on maintenance treatment with antidepressants in primary care. Nevertheless, depression guidelines recommend maintenance treatment i.e. treatment to prevent recurrences, in patients with high risk of recurrence, and many patients use maintenance treatment with antidepressants. This study explores the characteristics of patients on maintenance treatment with antidepressants in general practice, and compares these characteristics with guideline recommendations for maintenance treatment. METHODS: We used data (baseline, two-year and four-year follow-up) of primary care respondents with remitted depressive disorder (≥6 months) from the Netherlands Study of Depression and Anxiety (n = 776). Maintenance treatment was defined as the use of an antidepressant for ≥12 months. Multilevel logistic regression was used to describe the association between sociodemographic, clinical and care characteristics and use of maintenance treatment with antidepressants. RESULTS: Older patients, patients with a lower education, those using benzodiazepines or receiving psychological/psychiatric care and patients with a concurrent history of a dysthymic or anxiety disorder more often received maintenance treatment with antidepressants. LIMITATIONS: Measurements were not made at the start of an episode, but at predetermined points in time. Diagnoses were based on interview (CIDI) data and could therefore in some cases have been different from the GP diagnosis. CONCLUSIONS: Since patients with chronic or recurrent depression do not use maintenance treatment with antidepressants more often, characteristics of patients on maintenance treatment do not fully correspond with guideline recommendations. However, patients on maintenance treatment appear to be those with more severe disorder and/or more comorbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some people need long-term antidepressants to prevent relapse, but surveys suggest 30%–50% have no guideline-based indication for long-term use (eg, according to National Institute for Health and Care Excellence (NICE) Depression Guideline (2009)).6–8”
From Helping people discontinue long-term antidepressants: views of health professionals in UK primary care (2019) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 1×
“Clinical characteristics including current and past (last 6 months, last year, lifetime) diagnoses of MDD and dysthymia, comorbid anxiety disorders (panic disorder with and without agoraphobia, agoraphobia, social phobia and generalised anxiety disorder) were all assessed with the CIDI and severity of depression with…”
MethodKessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“Most patients are treated in primary care [2,3].”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“Depression is a common condition that has a chronic or recurrent course in a significant proportion of cases [1].”
BackgroundAssessment of suicidal intention: The Scale for Suicide Ideation.
Beck, A. T., Kovacs, M., & Weissman, A. (1979) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.47.2.343 · Cited by 3,419 · cited 1×
“The presence of suicide attempts in the past was measured with the Beck Suicide Ideation Scale [24].”
MethodNational Collaborating Centre for Mental Health
Veale, D. M. (2006) · Research Portal (King's College London) · Cited by 941
The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Penninx, B. W. J. H., Beekman, A. T. F., Smit, J. H., Zitman, F. G., Nolen, W. A., Spinhoven, P., Cuijpers, P., De Jong, P. J., Van Marwijk, H. W. J., Assendelft, W. J. J., et al. (2008) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.256 · Cited by 927 · cited 3×
“Detailed information on the objectives, study population and methods of NESDA has been published [13].”
BackgroundMethodInfluentialSelf-citationThe inventory for depressive symptomatology (IDS): Preliminary findings
John Rush, A., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J., & Burns, C. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90060-0 · Cited by 918 · cited 1×
“Clinical characteristics including current and past (last 6 months, last year, lifetime) diagnoses of MDD and dysthymia, comorbid anxiety disorders (panic disorder with and without agoraphobia, agoraphobia, social phobia and generalised anxiety disorder) were all assessed with the CIDI and severity of depression with…”
MethodWittchen, H.-U., Robins, L. N., Cottler, L. B., Sartorius, N., Burke, J. D., Regier, D., & Trials, P. I. T. M. W. F. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.5.645 · Cited by 833
Applied Multilevel Analysis: A Practical Guide for Medical Researchers
Twisk, J. W. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610806 · Cited by 685 · cited 1×
“The Wald test was also used on the variance parameters to obtain an indication of the necessity for allowing a random intercept or regression coefficient into the model [28].”
MethodBauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477 · cited 1×
“However, the various guidelines, such as the NICE guideline depression in adults, the ICSI Health Care guideline major depression in adults in primary care and the Dutch General practitioners guideline depression (NHG-standaard Depressieve stoornis) use different indicators for patients at increased risk of recurrence…”
Method
Research works printed but not linked: 2
- Twisk JWR (2006) Applied multilevel analysis: A practical guide. Cambridge: Cambridge University Press. 196 p.
- Terluin B, Van Heest F, Van der Meer K, Neomagus G, Hekman J, et al (2004) NHG-standaard angststoornissen (eerste herziening). Huisarts en Wetenschap 47: 26– 37.
Cited by
Maund, E., Dewar-Haggart, R., Williams, S., Bowers, H., Geraghty, A. W. A., Leydon, G., May, C., Dawson, S., & Kendrick, T. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.107 · Cited by 90
Managing antidepressant discontinuation: a systematic review
Maund, E., Stuart, B., Moore, M., Dowrick, C., Geraghty, A. W. A., Dawson, S., & Kendrick, T. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2336 · Cited by 82
Animal models of recurrent or bipolar depression
Kato, T., Kasahara, T., Kubota-Sakashita, M., Kato, T. M., & Nakajima, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.016 · Cited by 45
“Although antidepressants were developed to ameliorate the symptoms of acute depression and approved based on this efficacy (Inada and Inagaki, 2015), they are also prescribed to prevent relapses (Piek et al., 2014).”
Bowers, H. M., Williams, S. J., Geraghty, A. W. A., Maund, E., O’brien, W., Leydon, G., May, C. R., & Kendrick, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027837 · Cited by 31
Bowers, H. M., Kendrick, T., Głowacka, M., Williams, S. J., Leydon, G., May, C. R., Dowrick, C. F., Moncrieff, J., Laine, R., Nestoriuc, Y., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032312 · Cited by 34
Metadata
- Authors
- Piek, E., Kollen, B. J., van der Meer, K., Penninx, B. W. J. H., & Nolen, W. A.
- Affiliations
- University Medical Center Groningen (NL)
- Corresponding author
- Piek, Ellen
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-05-23
- Volume
- 9
- Issue
- 5
- Pages
- e97463
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4032267
- OpenAlex
- W1993115734
- Cited by
- 24
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 1 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- World Health Organization
- Stanley Medical Research Institute
- European Commission
- Universiteit Leiden (10‐000‐1002)
- ZonMw (10‐000‐1002)
- Vrije Universiteit Amsterdam
- GGZ inGeest
- Rivierduinen
- GGZ Friesland
- GGZ Drenthe
- Nederlands Instituut voor Onderzoek van de Gezondheidszorg (10-000-1002)
- Trimbos-instituut
- Leids Universitair Medisch Centrum
- Universitair Medisch Centrum Groningen
- Servier
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, guideline adherence, primary care, remitted depression, recurrence prevention, benzodiazepines, comorbidities, dysthymia, anxiety disorders, sociodemographic factors
- MeSH terms
- Antidepressive Agents, Anxiety, Demography, Depression, Female, Humans, Male, Middle Aged, Netherlands, Primary Health Care, Comorbidity, Multivariate Analysis, Guideline Adherence, General Practice, Maintenance Chemotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.